1. M. Hallbrink, A. Floren, A. Elmquist, M. Pooga, T. Bartfai and U. Langel, Cargo delivery kinetics of cell-penetrating peptides, Biochim. Biophys. Acta, 2001, 1515: 101–109.
2. M. Tyagi, M. Rusnati, M. Presta and M. Giacca, Internalization of HIV-1 TAT requires cell surface heparan sulfate proteoglycans, J. Biol. Chem. 2001, 276:3254–3261.
3. S. Violini, V. Sharma, J.L. Prior, M. Dyszlewski and D. Piwnica-Worms, Evidence for a plasma membrane-mediated permeability barrier to TAT basic domain in well-differentiated epithelial cells: lack of correlation with heparan sulfate, Biochemistry2002, 41: 12652–12661.
4. E. Vives, P. Brodin and B. Lebleu, A truncated HIV-1 TAT protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus, J. Biol. Chem. 1997,272: 16010–16017
5. D. Derossi, S. Calvet, A. Trembleau, A. Brunissen, G. Chassaing and A. Prochiantz, Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent, J. Biol. Chem. 1996,271: 18188–18193.
6. P. Moy, Y. Daikh, B. Pepinsky, D. Thomas, S. Fawell and J. Barsoum, TAT-mediated protein delivery can faciliTATe MHC class I presenTATion of antigens, Mol. Biotechnol. 1996，6: 105–113.
7. D.T. Kim, D.J. Mitchell, D.G. Brockstedt, L. Fong, G.P. Nolan, C.G. Fathman, E.G. Engleman and J.B. Rothbard, Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV TAT peptide, J. Immunol. 1997，159:1666–1668.
8. H.Y. Kwon, W.S. Eum, H.W. Jang, J.H. Kang, J. Ryu, B. Ryong Lee, L.H. Jin, J. Park and S.Y. Choi, Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 TAT protein basic domain into mammalian cells, FEBS Lett. 2000，485:163–167.
9. P.S. Kabouridis, M. Hasan, J. Newson, D.W. Gilroy and T. Lawrence, Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha,J. Immunol. 2002, 169: 2587–2593.
10. N. Shibagaki and M.C. Udey, Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity, J. Immunol. 2002, 168: 2393–2401.
11. H.Y. Wang, T. Fu, G. Wang, G. Zeng, D.M. Perry-Lalley, J.C. Yang, N.P. Restifo, P. Hwu and R.F. Wang, Induction of CD4(+) T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells, J. Clin. Invest. 2002,109: 1463–1470.
12. G.E. Roeder, J.L. Parish, P.L. Stern and K. Gaston, Herpes simplex virus VP22–human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death, Biotechnol. Appl. Biochem. 2004,40: 157–165.
13. D.C. Anderson, E. Nichols, R. Manger, D. Woodle, M. Barry and A.R. Fritzberg, Tumor cell retention of antibody Fab fragments is enhanced by an attached HIV TAT protein-derived peptide, Biochem. Biophys. Res. Commun. 1993, 94: 876–884.
14. S. Stein, A. Weiss, K. Adermann, P. Lazarovici, J. Hochman and H. Wellhoner, A disulfide conjugate between anti-tetanus antibodies and HIV (37–72) TAT neutralizes tetanus toxin inside chromaffin cells, FEBS Lett. 1999, 458: 383–386.
15.Tachikawa K, Schroder O, Frey G, Briggs SP and Sera T, Regulation of the endogenous VEGF-A gene by exogenous designed regulatory proteins, Proc Natl Acad Sci U S A. 2004,101(42): 15225-30.
16. Oehlke J, Wallukat G, Wolf Y, Ehrlich A, Wiesner B, Berger H and Bienert M, Enhancement of intracellular concentration and biological activity of PNA after conjugation with a cell-penetrating synthetic model peptide. Eur J Biochem. 2004, 271(14):3043-9.
17. F. Simeoni et al., Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 2003，31: 2717–2724.
18. V. Polyakov, V. Sharma, J.L. Dahlheimer, C.M. Pica, G.D. Luker and D. Piwnica-Worms, Novel TAT-peptide chelates for direct transduction of technetium-99 m and rhenium into human cells for imaging and radiotherapy, Bioconjug. Chem. 2000，11: 762–771.
19. V.P.Torchilin,T.S.Levchenko,R.Rammohan,N.Volodina,B.Papahadjopoulos-Sternberg and G.G. D'Souza, Cell transfection in vitro and in vivo with nontoxic TAT peptide–liposome–DNA complexes, Proc. Natl. Acad. Sci. U. S. A. 2003，100:1972–1977.